Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, indicating a backend/template update. This change does not modify the displayed study details or navigation.
    Difference
    0.0%
    Check dated 2026-05-17T10:16:11.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    This updates the page’s technical revision/version label to v3.5.3 from v3.5.2, with no visible change to the study record details presented.
    Difference
    0.0%
    Check dated 2026-04-25T17:52:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:15:48.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' to the content and included a new Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-03-27T21:59:36.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision stamp updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T19:35:39.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T14:57:23.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.